参考文献/References:
[1]Sung H,Ferlay J,Siegel RL,et al.Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J].CA Cancer J Clin,2021,71(3):209-249.[2]Kubecek O,Laco J,Spacek J,et al.The pathogenesis, diagnosis, and management of metastatic tumors to the ovary: a comprehensive review[J].Clin Exp Metastasis,2017,34(5):295-307. [3]Jeung YJ,Ok HJ,Kim WG,et al.Krukenberg tumors of gastric origin versus colorectal origin[J].Obstet Gynecol Sci,2015,58(1):32-39.[4]朱学聪.血浆纤维蛋白原水平同胃癌肝转移临床病理参数的关系和预测疗效及预后的价值[D].石家庄:河北医科大学,2016.[5]Saito H,Kono Y,Murakami Y,et al.Prognostic Significance of Pre- and Postoperative Lymphocyte Counts in Patients with Gastric Cancer[J].Dig Surg,2019,36(2):137-143.[6]Yamamoto M,Kurokawa Y,Kobayashi N,et al.Prognostic Value of the Combined Index of Plasma Fibrinogen and the Neutrophil-Lymphocyte Ratio in Gastric Cancer[J].World J Surg,2020,44(1):207-212. [7]Yamamoto M,Kurokawa Y,Miyazaki Y,et al.Usefulness of Preoperative Plasma Fibrinogen Versus Other Prognostic Markers for Predicting Gastric Cancer Recurrence[J].World J Surg,2016,40(8):1904-1909.[8]田艳涛,马福海.胃癌卵巢转移的诊治策略[J].中华肿瘤杂志,2019,41(3):178-182.[9]Zhao G,Liu N,Wang S,et al.Prognostic significance of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in patients with metastatic gastric cancer[J].Medicine,2020,99(10):e19405.[10]Zhang X,Zhao W,Yu Y,et al.Clinicopathological and prognostic significance of platelet-lymphocyte ratio (PLR) in gastric cancer: an updated meta-analysis[J].World J Surg Oncol,2020,18(1):191. [11]Yamashita H,Kitayama J,Nagawa H.Hyperfibrinogenemia is a useful predictor for lymphatic metastasis in human gastric cancer[J].Jpn J Clin Oncol,2005,35(10):595-600. [12]Feng F,Liu J,Wang F,et al.Prognostic value of differentiation status in gastric cancer[J].BMC Cancer,2018,18(1):865.[13]Williams KA,Labidi-Galy SI,Terry KL,et al.Prognostic significance and predictors of the neutrophil-to-lymphocyte ratio in ovarian cancer[J]. Gynecol Oncol,2014,132(3):542-550.[14]Hirahara T,Arigami T,Yanagita S,et al.Combined neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with advanced gastric cancer[J].BMC Cancer,2019,19(1):672.[15]邓中波.中性粒细胞与淋巴细胞比率在T4期胃癌患者中的应用研究[D].合肥:安徽医科大学,2019.[16]Shimada H,Takiguchi N,Kainuma O,et al.High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer[J].Gastric Cancer,2010,13(3):170-176.
相似文献/References:
[1]尹晓华,刘重元,黄 琳,等.胃癌中lncRNAs的研究进展[J].医学信息,2018,31(03):10.[doi:10.3969/j.issn.1006-1959.2018.03.004]
YIN Xiao-hua,LIU Zhong-yuan,HUANG Lin,et al.Research Progress of lncRNAs in Gastric Cancer[J].Medical Information,2018,31(23):10.[doi:10.3969/j.issn.1006-1959.2018.03.004]
[2]芮昆昆,章 波,邰小华,等.基质金属蛋白酶2与蛋白磷酸酶2A的癌性抑制因子在胃癌中的研究进展[J].医学信息,2018,31(03):21.[doi:10.3969/j.issn.1006-1959.2018.03.007]
RUI Kun-kun,ZHANG Bo,TAI Xiao-hua,et al.The Research Progress of Matrix Metalloproteinase 2 and Cancer Inhibitor of Protein Phosphatase 2A in Gastric Cancer[J].Medical Information,2018,31(23):21.[doi:10.3969/j.issn.1006-1959.2018.03.007]
[3]段 巍.1例晚期胃癌化疗并发嗜血细胞综合征患者的护理[J].医学信息,2018,31(10):181.[doi:10.3969/j.issn.1006-1959.2018.10.063]
DUAN Wei.Nursing Care of a Case of Advanced Gastric Carcinoma with Hemophagocytic Syndrome after Chemotherapy[J].Medical Information,2018,31(23):181.[doi:10.3969/j.issn.1006-1959.2018.10.063]
[4]潘理会,李育庄,李春辉.胃癌与高凝血状态关系的研究现状[J].医学信息,2018,31(11):15.[doi:10.3969/j.issn.1006-1959.2018.11.005]
PAN Li-hui,LI Yu-zhuang,LI Chun-hui.Research Status of the Relationship between Gastric Carcinoma and Hypercoagulable State[J].Medical Information,2018,31(23):15.[doi:10.3969/j.issn.1006-1959.2018.11.005]
[5]李虹霞,刘伏山.慢性萎缩性胃炎的中西医治疗[J].医学信息,2022,35(11):29.[doi:10.3969/j.issn.1006-1959.2022.11.009]
LI Hong-Xia,LIU Fu-shan.Treatment of Chronic Atrophic Gastritis with Traditional Chinese and Western Medicine[J].Medical Information,2022,35(23):29.[doi:10.3969/j.issn.1006-1959.2022.11.009]
[6]梁延洋,程艳娜,华柏慧,等.胃癌合并2型糖尿病术后血糖改善的临床观察[J].医学信息,2018,31(17):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
LIANG Yan-yang,CHENG Yan-na,HUA Bai-hui,et al.Clinical Observation of Postoperative Blood Glucose Improvement in Patients with Gastric Cancer Complicated with Type 2 Diabetes Mellitus[J].Medical Information,2018,31(23):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
[7]林跃韩,许庆文.腹腔镜uncut Roux-en-Y吻合与传统吻合方式的研究进展[J].医学信息,2018,31(22):31.[doi:10.3969/j.Ⅰssn.1006-1959.2018.22.010]
LIN Yue-han,XU Qing-wen.Research Progress of Laparoscopic uncut Roux-en-Y Anastomosis and Traditional Anastomosis[J].Medical Information,2018,31(23):31.[doi:10.3969/j.Ⅰssn.1006-1959.2018.22.010]
[8]马玉涛,石文娜,李晓林,等.免疫荧光法检测FSHR与GnRHR在胃癌组织中的分布及其共定位研究[J].医学信息,2018,31(23):79.[doi:10.3969/j.issn.1006-1959.2018.23.022C]
MA Yu-tao,SHI Wen-na,LI Xiao-lin,et al.Study on the Distribution and Co-localization of FSHR and GnRHR in Gastric Cancer Tissues by Immunofluorescence Assay[J].Medical Information,2018,31(23):79.[doi:10.3969/j.issn.1006-1959.2018.23.022C]
[9]赵 静.血浆纤维蛋白原和CA724水平在胃癌患者的变化及临床意义[J].医学信息,2018,31(24):82.[doi:10.3969/j.issn.1006-1959.2018.24.021]
ZHAO Jing.Changes and Clinical Significance of Plasma Fibrinogen and CA724 Levels in Patients with Gastric Cancer[J].Medical Information,2018,31(23):82.[doi:10.3969/j.issn.1006-1959.2018.24.021]
[10]万 芳.以贫血为首发症状的消化道恶性肿瘤临床分析[J].医学信息,2018,31(24):175.[doi:10.3969/j.issn.1006-1959.2018.24.054]
WAN Fang.Clinical Analysis of Digestive Tract Malignancies with Anemia as the First Symptom[J].Medical Information,2018,31(23):175.[doi:10.3969/j.issn.1006-1959.2018.24.054]